Dr Vinayak S Hiremath

Dr Vinayak S Hiremath Medical Director| Dr Vinayak’s Metabolic Clinic & Research Centre| KMK Hospital|Editor International Journal of Medicine & Surgery| Pride of Nation Award 2019

Somewhere between a hundred patients in the OPD and the last file of the day, I have always tried to leave a little room...
13/08/2026

Somewhere between a hundred patients in the OPD and the last file of the day, I have always tried to leave a little room for young minds and their questions.

This batch of FMG interns spent the last two months observing with me.

I was supposed to teach them.

But medicine has a strange way of keeping the teacher honest.

A casual “Why, sir?” can send you back to a chapter you haven’t opened in years. A doubt between two patients can follow you home, make you search for a paper, revisit an old concept, and occasionally question something you have been doing almost instinctively.

Perhaps that is why, however busy practice becomes, I never want to give up teaching.

Patients give us experience.
Young doctors make us examine that experience.

Today, before flying back to Europe to complete their medical degrees, they came by with a small token for me.

The gift was lovely.

But what stayed with me was the thought that two months had already passed.

Soon they will be in different hospitals, different countries, learning from different teachers, eventually standing on the other side of the table with patients of their own.

I hope they carry something useful from these two months.

I certainly do.

A few memories.
A few questions I still need to read about.
And the reassuring feeling that another generation is falling in love with medicine in its own way.

Fly back, finish what you started, and become good doctors.

Not merely doctors who know the answers—

but doctors who never lose the habit of asking better questions.

Wishing each of you the very best for the road ahead.

And thank you for the little gift.
The questions were the better one.

ClinicalMedicine MedicineBeyondTextbooks LearningMedicine LifeInMedicine DoctorsOfTomorrow FMG FMGStudents MedicalInterns ClinicalTraining InternalMedicine PhysicianLife DoctorsOfIndia MedicineIsALifelongJourney NeverStopLearning PassingTheTorch

SEMASIZE by Alkem | A Conversation on SemaglutideThank you Alkem for inviting me to speak on a molecule that continues t...
12/08/2026

SEMASIZE by Alkem | A Conversation on Semaglutide

Thank you Alkem for inviting me to speak on a molecule that continues to reshape the landscape of obesity and metabolic medicine — semaglutide.

What makes these conversations increasingly meaningful is how rapidly the GLP-1 space is evolving.

With every passing day, more physicians are gaining experience with GLP-1 receptor agonists — prescribing them, observing outcomes, asking sharper questions, discussing adverse effects, challenging misconceptions and, importantly, sharing their real-world experiences.

And that is exactly how good medicine progresses.

From excitement → to questions → to evidence → to responsible clinical practice.

The conversation around obesity pharmacotherapy is gradually moving beyond simply “How much weight can we lose?” toward the questions that truly matter:

Who should receive treatment?
How do we individualise therapy?
How do we preserve muscle and metabolic health?
How do we manage adverse effects?
And how do we sustain outcomes for the long term?

Every question raised and every clinical experience shared adds another layer to the scientific environment we are collectively building around obesity, weight management and GLP-1–based therapies.

Thank you to everyone who took time out to attend, interact, question and contribute.

The science is evolving.
Our understanding is evolving.
And so must the way we treat obesity.

Thank you for the warmth, the engagement and a wonderfully scientific evening.

Hips don’t lie - but neither does science.For decades, BMI has been the most widely used measure to define obesity. Whil...
29/07/2026

Hips don’t lie - but neither does science.

For decades, BMI has been the most widely used measure to define obesity. While it remains a useful screening tool, it doesn’t reveal where fat is stored or whether it is putting your health at risk.

Many Indians develop excess visceral fat despite having a “normal” BMI—a phenotype associated with type 2 diabetes, MASLD, hypertension, cardiovascular disease, and other metabolic disorders.

That is why modern obesity care increasingly looks beyond BMI, incorporating waist circumference, waist-to-hip ratio, body composition, and metabolic risk assessment for a more complete picture of health.

At Dr. Vinayak’s Metabolic Clinic & Research Centre, we believe obesity is not simply about body weight—it’s about understanding the biology behind it.

Know your waist. Understand your risk. Take control of your metabolic health.

Some conversations don’t end when the session does they continue in the minds of everyone in the room.Grateful to Physic...
20/07/2026

Some conversations don’t end when the session does they continue in the minds of everyone in the room.

Grateful to Physicians’ Club Chalakudy and Sun Pharma for the invitation and the opportunity to share an evening of science, discussion, and collaboration.

Over the years, I’ve had the privilege of meeting hundreds of physicians learning from their experiences, exchanging perspectives, and growing with every conversation. Every CME reminds me that medicine advances not through individual knowledge, but through collective curiosity.

Yesterday’s discussion focused on the evolving science of dyslipidemia moving beyond conventional cholesterol testing to understand Lp(a), ApoB, residual cardiovascular risk, advanced imaging, and the practical application of the 2026 Dyslipidemia Guidelines. More importantly, we explored who truly needs testing, who benefits from treatment, and how to identify patients who remain at risk despite having “normal” cholesterol levels.

Thank you to everyone who attended, challenged ideas with thoughtful questions, and shared your clinical experiences. Those discussions are always the most rewarding part of any lecture.

Here’s to continuing to question, learn, and practice evidence-based medicine one conversation at a time. 🤍

EvidenceBasedMedicine MedicalEducation CME SunPharma PhysiciansClubChalakudy InternalMedicine Endocrinology

India now has a once-weekly basal insulin. My feed is full of posts celebrating it. Almost none of them mention the part...
09/07/2026

India now has a once-weekly basal insulin. My feed is full of posts celebrating it. Almost none of them mention the part that matters most to the person actually injecting it:

You cannot take back a week’s worth of insulin.

Mild lows were more common in the trials. In type 1 diabetes, significant lows were roughly twice as frequent as with daily insulin. That doesn’t make this a bad drug — it makes it a drug that demands a conversation, not a purchase.

Swipe through.

Then take it to your endocrinologist and ask: “Is this right for me, or just convenient for me?”

—

Educational content. Not medical advice. Not a product endorsement.

DiabetesEducation HbA1c Hypoglycemia BloodSugar DiabetesIndia MetabolicHealth PatientEducation Kerala

07/07/2026

Tomorrow. 8:00 PM.

A conversation beyond cholesterol.

Who needs which test?
What should your LDL target really be?
When should you measure Lp(a) or ApoB?
Is Coronary Artery Calcium (CAC) scoring superior to carotid intima-media thickness in risk prediction?

And the question that changes everything...

Why do some patients suffer a heart attack or stroke despite having "normal" LDL or cholesterol levels?

Because cardiovascular risk extends far beyond the routine lipid profile.

Join me as we unpack the 2026 Dyslipidemia Guidelines, landmark clinical trials, emerging biomarkers, advanced imaging, and practical strategies that are reshaping preventive cardiology.

Evidence-based.
Research-rich.
Grounded in real-world clinical practice.

Looking forward to an engaging discussion.

Forever drawn to conversations that challenge the mind. ✨🧬There’s something incredibly fulfilling about sitting in a roo...
06/07/2026

Forever drawn to conversations that challenge the mind. ✨🧬

There’s something incredibly fulfilling about sitting in a room where science isn’t just presented—it’s questioned, debated, and explored. Every question sparks another perspective, every discussion uncovers another layer, and every answer leaves me wanting to learn even more. The moment a complex concept finally makes perfect sense… that satisfaction is simply unmatched.

Honoured to be invited by Qualified Private Medical Practitioners Association (QPMPA) and Novo Nordisk for an enriching expert session.

The greatest luxury is being surrounded by people who inspire you to think deeper. Learning from the real OGs of clinical practice, exchanging ideas, meeting brilliant minds, building meaningful connections, and walking away with fresh perspectives—it doesn’t get better than this.

Here’s to staying endlessly curious, choosing knowledge over assumptions, and falling in love with the science, every single time. 🤍✨

ScienceMeetsPractice LifelongLearning Networking Medicine GrowthMindset

THANK YOU 🤍Thank you so much for taking a moment to wish me.Your kind words genuinely made my Doctor’s Day so special. E...
01/07/2026

THANK YOU 🤍

Thank you so much for taking a moment to wish me.

Your kind words genuinely made my Doctor’s Day so special. Every message brought a smile and reminded me how fortunate I am to be on this journey.

Thank you for being a part of it and for encouraging the passion that keeps me going every single day.

From the bottom of my heart, I wish you and your family a lifetime of happiness and, most importantly, the very best of health. ❤️🩺

26/06/2026

Planning a pregnancy on a GLP-1? When you stop matters — and why matters more.

Mounjaro (tirzepatide): stop ≥1 month before trying to conceive.
Wegovy/Ozempic (semaglutide): stop ≥2 months before.

Why the difference? Purely timing. Semaglutide stays in the body longer (half-life ~1 week vs ~5 days), so it needs a longer runway to clear. That’s all the half-life explains.

So why stop at all? Not because these drugs are proven dangerous in pregnancy because they’re untested in pregnancy. We don’t yet have enough human safety data, animal studies flagged caution, and weight loss carries no benefit for a developing baby.

Risk without benefit = we pause. Simple, precautionary, sensible

If you conceive unexpectedly while on one: don’t panic. Stop the medication and contact your doctor. Reassuringly, women who were exposed early before they knew have not shown higher rates of birth defects in studies to date.

One under-discussed point: tirzepatide can reduce the absorption of oral contraceptive pills in the first 4 weeks and after each dose increase. If you’re on the pill, add a barrier method or switch to a non-oral option during those windows.

Bottom line: follow the guidance for your specific molecule not “GLP-1s” as a blanket. And plan it with your doctor.

If this helps someone in your network, repost. 🔁



PregnancyPlanning PreconceptionHealth TTC (Trying To Conceive) ObesityMedicine FertilityAwareness

Some talks satisfy.Some inspire.And a rare few leave you walking out feeling like you’re floating.Last evening was one o...
24/06/2026

Some talks satisfy.
Some inspire.
And a rare few leave you walking out feeling like you’re floating.

Last evening was one of those moments.

Standing before a hall filled with stalwarts, HODs, senior faculty and colleagues, discussing Ozempic® and its evolving role in MAFLD/MASH, was an honour in itself.

What made the evening truly special, however, were the moments after the talk—the thoughtful questions, engaging discussions, warm handshakes, encouraging words, and the genuine appreciation from people whose work I have admired for years.

Being called the “Star of the Day” by several colleagues was unexpected, humbling, and incredibly motivating.

As one of the younger speakers in the room, those words meant more than I can express.

Thank you Novo Nordisk, Cochin Diabetic Club, and every delegate who participated, questioned, challenged, appreciated, and contributed to making the session memorable.

Medicine gives us many milestones.
Some are measured in publications, positions, or achievements.

And then there are evenings like these.

The kind you quietly frame in your mind and carry with you for years.

❤️✨

Address

KMK HOSPITAL, KMK Junction, NORTH PARAVUR, ERNAKULAM
Kochi
683513

Opening Hours

Monday 9am - 8pm
Tuesday 9am - 8pm
Wednesday 9am - 8pm
Thursday 9am - 8pm
Friday 9am - 8pm
Saturday 9am - 2pm

Telephone

+919074563508

Website

Alerts

Be the first to know and let us send you an email when Dr Vinayak S Hiremath posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Dr Vinayak S Hiremath:

Shortcuts

Share

Category